Print

Curis, Inc. (CRIS) to Present at Upcoming Investor Conferences  
9/4/2012 9:40:42 AM

LEXINGTON, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will present at the following upcoming conferences:
//-->